US drugmaker is trying to chart its future without blockbuster Covid-19 products
Pfizer shares tumble on weak forecast for 2024 revenues
Recent Posts
- Your summer holiday is a retirement killer
- Blackwater founder Erik Prince: Trump was ‘badly advised’ on Iran
- How quickly should a battered Venezuela restructure its debt?
- Volkswagen to axe up to 100,000 jobs in sweeping cost-cutting drive
- Brutal nights and humidity mark Europe’s record June temperatures
